shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Entertainment News > Hollywood News > Article > Adria Arjona in talks to join Morbius

Adria Arjona in talks to join Morbius

Updated on: 18 December,2018 04:28 PM IST  |  Mumbai
IANS |

Adria Arjona would play Martine Bancroft, who in the comics was engaged to Dr Michael Morbius

Adria Arjona in talks to join Morbius

Adria Arjona

"Pacific Rim" star Adria Arjona is in early negotiations to join Jared Leto in "Morbius". According to the Hollywood Reporter, if things workout, Arjona would play Martine Bancroft, who in the comics was engaged to Dr Michael Morbius. In the comics, Morbius was a scientist who suffered from a rare blood disease and turned himself into a living vampire while seeking a cure.


Bancroft made her debut in 1971's comics 'Amazing Spider-Man No. 102' and could be said to be accidentally responsible for Morbius' transformation into a vampire-like creature, as it's the human Morbius' love for her that drives him to experiment on himself. Scandinavian filmmaker Daniel Espinosa is directing "Morbius" from a script by Burk Sharpless and Matt Sazama. Avi Arad and Matt Tolmach will produce with Lucas Foster.


Catch up on all the latest entertainment news and gossip here. Also download the new mid-day Android and iOS apps to get latest updates


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK